Sono-Tek (SOTK) - 2026 Q2 - Quarterly Results

Form 8-K Filing Details This section outlines Sono-Tek Corporation's fundamental identification and contact information for its 8-K filing Registrant and Filing Information This section details Sono-Tek Corporation's legal name, state of incorporation, principal executive offices, and contact number - Registrant: Sono-Tek Corporation[1] - State of Incorporation: New York[1] - Principal Executive Offices: 2012 Route 9W, Milton, New York 12547[1] - Telephone Number: (845) 795-2020[1] Securities Registration and Emerging Growth Company Status This section details the registrant's registered securities and confirms its status regarding the 'emerging growth company' definition | Title of each class | Symbol(s) | Name of each exchange on which registered | | :------------------ | :-------- | :---------------------------------------- | | Common Stock, $0.01 par value per share | SOTK | NASDAQ | - Sono-Tek Corporation is not an 'emerging growth company' as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934[3] Current Report Event Disclosure This section discloses significant events reported in the 8-K, including a major order and related legal disclaimers Item 2.02: Results of Operations and Financial Condition & Item 7.01: Regulation FD Disclosure This section details a significant medical device coating systems order and clarifies the legal status of the furnished information Medical Device Coating Systems Order Sono-Tek Corporation announced a substantial order for medical device coating systems, indicating a positive operational development - Sono-Tek Corporation received an order for medical device coating systems valued at over $5 Million[4] - The order was announced via a press release dated September 3, 2025[4] Information Furnishing Disclaimer A standard disclaimer clarifies the legal status of the information provided under Item 2.02 and Item 7.01 - The information furnished pursuant to Item 2.02 and Item 7.01, including Exhibit 99.1, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934[5] - This information is also not subject to the liabilities under Section 18 and shall not be deemed incorporated by reference into any Company filing under the Securities Act of 1933 or the Exchange Act[5] Exhibits and Signatures This section lists the accompanying exhibits and confirms the official signing of the report Item 9.01: Financial Statements and Exhibits This section lists the exhibit accompanying the 8-K filing, which is the press release detailing the significant order - Exhibit 99.1 is the press release dated September 3, 2025, regarding the medical device coating systems order[6] Signatures The report is duly signed by an authorized officer of Sono-Tek Corporation - The report was signed by Stephen J. Bagley, Chief Financial Officer of Sono-Tek Corporation[6] - The signing date was September 3, 2025[6]